Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Randomised, Controlled and Unicenter Clinical Trial to Assess the Efficiency of Pirfenidone for the Reduction of Pulmonary Metabolic, Inflammatory and Fibrogenic Activity in Patients With Silicosis Due to Artificial Stone and PMF

NCT05118256 is registered in ClinicalTrials.gov with Instituto de investigación e innovación biomédica de Cádiz as lead sponsor.

NCT NCT05118256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05118256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Randomised, Controlled and Unicenter Clinical Trial to Assess the Efficiency of Pirfenidone for the Reduction of Pulmonary Metabolic, Inflammatory and Fibrogenic Activity in Patients With Silicosis Due to Artificial Stone and PMF
Lead sponsor
Instituto de investigación e innovación biomédica de Cádiz
Phase
Phase 2
Overall status
Unknown status
Start date
November 15, 2021
Completion date
November 15, 2023
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complicated silicosis, progressive massive fibrosis, silicosis